Cefoperazone Sodium/Tazobactam Sodium

头孢哌酮钠/他唑巴坦钠

Report date: 2026/04/21 20:00:18

Base Information

Drug NameCefoperazone Sodium/Tazobactam Sodium
Drug Alias Name头孢哌酮钠他唑巴坦钠
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitorsBeta Lactamase inhibitors
TargetsBacterial penicillin-binding proteinBeta Lactamase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Cefoperazone SodiumTazobactam Sodium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01DD62
Related LinksN/A